Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
China
· Delayed Price · Currency is CNY 17.41
+0.24 (1.40%)
Apr 24, 2025, 3:04 PM CST
SHE:002932 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Net Income | 10.56 | 74.93 | 4,208 | 1,413 | 468.93 | 41.53 | Upgrade
|
| Depreciation & Amortization | 83.4 | 83.4 | 59.08 | 23.63 | 17.24 | 16.78 | Upgrade
|
| Other Amortization | 11.82 | 11.82 | 2.65 | 0.87 | 0.87 | 0.81 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.31 | -0.31 | -0.01 | - | -0.15 | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | -4.58 | -4.58 | 646.56 | 21.33 | 6.5 | 0.64 | Upgrade
|
| Loss (Gain) From Sale of Investments | -125.14 | -125.14 | -37.88 | -0.67 | -1.31 | -4.66 | Upgrade
|
| Other Operating Activities | -215.82 | 3.29 | 153.33 | 34.62 | 7.33 | 0.98 | Upgrade
|
| Change in Accounts Receivable | 1,256 | 1,256 | -2,325 | -722.32 | -320.05 | -4.12 | Upgrade
|
| Change in Inventory | 342.82 | 342.82 | -473.38 | -166.86 | -78.58 | -19.47 | Upgrade
|
| Change in Accounts Payable | -1,302 | -1,302 | 1,539 | 530.21 | 265.58 | -8.87 | Upgrade
|
| Change in Other Net Operating Assets | 79.95 | 79.95 | 370.01 | - | - | - | Upgrade
|
| Operating Cash Flow | 109.03 | 392.5 | 4,013 | 1,127 | 359.68 | 22.49 | Upgrade
|
| Operating Cash Flow Growth | -95.22% | -90.22% | 256.06% | 213.33% | 1499.59% | -58.10% | Upgrade
|
| Capital Expenditures | -174.09 | -109.97 | -313.38 | -103.57 | -28.28 | -31.94 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.71 | 0.15 | - | - | 0.01 | 0 | Upgrade
|
| Investment in Securities | -1,593 | -1,290 | -1,958 | -588 | -22.9 | -70 | Upgrade
|
| Other Investing Activities | 7.11 | 34.71 | 37.18 | 6.45 | 7.81 | 4.67 | Upgrade
|
| Investing Cash Flow | -1,772 | -1,365 | -2,234 | -685.12 | -43.37 | -97.27 | Upgrade
|
| Short-Term Debt Issued | - | 23.61 | 137.39 | 30 | 141.5 | - | Upgrade
|
| Total Debt Issued | 3.77 | 23.61 | 137.39 | 30 | 141.5 | - | Upgrade
|
| Short-Term Debt Repaid | - | -125 | -53.42 | -141.5 | - | -2.79 | Upgrade
|
| Long-Term Debt Repaid | - | -20.49 | -4.72 | -2.95 | - | - | Upgrade
|
| Total Debt Repaid | -119.64 | -145.49 | -58.14 | -144.45 | - | -2.79 | Upgrade
|
| Net Debt Issued (Repaid) | -115.87 | -121.87 | 79.24 | -114.45 | 141.5 | -2.79 | Upgrade
|
| Issuance of Common Stock | - | - | - | 482.71 | 49.39 | - | Upgrade
|
| Repurchase of Common Stock | -0.53 | -0.53 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -32.03 | -582.48 | -550.64 | -283.39 | -8.44 | -19.98 | Upgrade
|
| Other Financing Activities | -159.13 | 34.83 | 38.6 | -2.6 | 0.47 | 0.5 | Upgrade
|
| Financing Cash Flow | -307.56 | -670.06 | -432.79 | 82.27 | 182.92 | -22.27 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.99 | 1.26 | 19.47 | -3.2 | -0.64 | 0.01 | Upgrade
|
| Net Cash Flow | -1,972 | -1,641 | 1,365 | 520.96 | 498.6 | -97.04 | Upgrade
|
| Free Cash Flow | -65.06 | 282.52 | 3,699 | 1,023 | 331.4 | -9.45 | Upgrade
|
| Free Cash Flow Growth | - | -92.36% | 261.47% | 208.82% | - | - | Upgrade
|
| Free Cash Flow Margin | -18.63% | 37.69% | 35.13% | 36.17% | 34.55% | -5.22% | Upgrade
|
| Free Cash Flow Per Share | -0.29 | 1.24 | 16.09 | 4.84 | 1.59 | -0.04 | Upgrade
|
| Cash Income Tax Paid | 11.05 | 268.9 | 1,253 | 219.86 | 87.78 | 20.74 | Upgrade
|
| Levered Free Cash Flow | -128.37 | 281.92 | 2,660 | 631.65 | 259.58 | -12.53 | Upgrade
|
| Unlevered Free Cash Flow | -122.25 | 288.49 | 2,662 | 632.97 | 259.99 | -12.53 | Upgrade
|
| Change in Net Working Capital | -53.04 | -298.24 | 323.83 | 416.54 | 100 | 19.3 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.